Cargando…
The Role of Lofexidine in Management of Opioid Withdrawal
Fear of withdrawal symptoms has been cited by survey respondents as the main reason that they continued to use opioids. Lofexidine is an α(2)-adrenergic agonist that decreases the sympathetic outflow that results in the characteristic symptoms of opioid withdrawal. A structural analog of clonidine,...
Autores principales: | Pergolizzi, Joseph V., Annabi, Hani, Gharibo, Christopher, LeQuang, Jo Ann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513979/ https://www.ncbi.nlm.nih.gov/pubmed/30565033 http://dx.doi.org/10.1007/s40122-018-0108-7 |
Ejemplares similares
-
Managing Opioid Withdrawal in an Outpatient Setting With Lofexidine or Clonidine
por: Gripshover, Jeanne, et al.
Publicado: (2022) -
Lofexidine for Treating Opioid Withdrawal Syndrome in Palliative Care Patients
por: Nair, Abhijit S
Publicado: (2018) -
Lofexidine for acute opioid withdrawal: A clinical case series
por: Renfro, Mandy L., et al.
Publicado: (2020) -
The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety
por: Pergolizzi Jr, Joseph V, et al.
Publicado: (2020) -
Safety and Efficacy of Lofexidine for Medically Managed Opioid Withdrawal: A Randomized Controlled Clinical Trial
por: Fishman, Marc, et al.
Publicado: (2019)